Jennifer R. Chapman-Fredricks, M.D.
- Fax: 305-689-7284
Pathogenesis and classification of lymphoid and hematopoietic malignancies.
- American Board of Pathology-Clinical
- American Board of Pathology-Anatomic
- American Board of Pathology-Hematopathology
- Assistant Professor of Pathology
- Director, Immunohistochemistry Laboratory
Dr. Chapman’s research focuses primarily on the identification of molecular genetic mechanisms of disease in lymphomagenesis and identification of useful diagnostic and prognostic markers of disease in lymphoma. Much of this effort is focused on the identification and understanding of molecular genetic events in the pathogenesis of diffuse large B cell lymphoma, orbital marginal zone lymphomas and EBV related lymphomas, in particular in plasmablastic lymphoma and EBV related large B cell lymphomas, with the ultimate goal of identifying new biomarkers of these diseases that can be used in both reproducible disease classification for diagnosis as well as identifying protein expression patterns that can be used to predict efficacy of targeted therapies. Dr Chapman is also directly involved in ongoing investigations focused on characterizing the gene and protein expression profiles of HTLV-1-related adult T –cell leukemia / lymphoma (ATLL) with the goal of identifying new prognostic and predictive biomarkers of disease through analysis of gene expression profiles by microarray studies. Dr Chapman has been primary author or significantly contributing co-author of over 20 manuscripts in the area of lymphoma and collaborates regularly with other pathologists as well as hematology / oncology clinical colleges in research endeavors.
Dr Chapman completed her medical education at the University of Miami, Miller School of Medicine, and received her MD in 2006. She subsequently completed her residency training in both clinical and anatomic pathology at the University of Miami and Jackson Memorial Hospital, followed by additional fellowship training in Hematopathology at the University of Miami, which was completed in 2011. Dr Chapman is board certified in clinical and anatomic pathology and is subspecialty boarded in hematology. Since joining the faculty of the Department of Pathology at the University of Miami as an Assistant Professor in 2011, Dr Chapman has been directly involved in the continued growth and development of the hematopathology section. She has also been as active participant in resident education, earning the CP Pathology teaching award in 2012, and as of September 2012 has been director of the Immunohistochemistry clinical and research laboratories for the Department of Pathology at the University of Miami.